Science Explorer Interactive view Map
Company · Munich · Germany

Daiichi Sankyo (Germany)

In research, Daiichi Sankyo (Germany) stands highest in Medicine (#4,600 of 17,978 worldwide), Health Sciences (#6,196 of 20,462 worldwide) and Life Sciences (#8,285 of 14,347 worldwide), over all time.

World rank, 2022–2025
#19,453
of 28,054 · #13,485 all time
Rank in Germany
#763
of 1,178
Research works
1.1k
▲ 9% vs 2013–17
Citations
22k
19.8 per fractional work
Top-10% rate
12.3%
record average 16.5%
Open access
63%
world 28%

What is Daiichi Sankyo (Germany) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #4,600 of 17,978 14.7%384
Health SciencesDomain #6,196 of 20,462 14.7%406
Life SciencesDomain #8,285 of 14,347 8.4%383
Physical SciencesDomain #15,784 of 21,541 6.1%255
Biochemistry, Genetics and Molecular BiologyField #6,027 of 7,814 8.5%240
Molecular BiologySubfield #4,621 of 4,961 8.2%158
ChemistryField #3,285 of 3,369 4.8%130

Each strip is that field’s whole ranked pool, with the notch where Daiichi Sankyo (Germany) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.27× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.61× its world share, 16 worksBiochemistry, Geneti…Immunology and Microbiology: 3.18× its world share, 4 worksImmunology and Micro…Neuroscience: 0.64× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.73× its world share, 2 worksPharmacology, Toxico…Chemical Engineering: 0.43× its world share, 0 worksChemical EngineeringChemistry: 0.84× its world share, 2 worksChemistryComputer Science: 0.07× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 0.09× its world share, 0 worksEarth and Planetary …Engineering: 0.36× its world share, 6 worksEngineeringEnvironmental Science: 0.35× its world share, 2 worksEnvironmental ScienceMaterials Science: 0.13× its world share, 0 worksMaterials ScienceMathematics: 0.80× its world share, 1 worksMathematicsPhysics and Astronomy: 0.07× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.43× its world share, 1 worksHealth ProfessionsMedicine: 2.67× its world share, 58 worksMedicineNursing: 1.26× its world share, 1 worksNursingArts and Humanities: 0.75× its world share, 2 worksArts and HumanitiesBusiness, Management and Accounting: 0.59× its world share, 2 worksBusiness, Management…Decision Sciences: 0.58× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 3.48× its world share, 8 worksEconomics, Econometr…Psychology: 0.18× its world share, 1 worksPsychologySocial Sciences: 0.19× its world share, 3 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 4.7×. Every wedge is a field page.

Who are the top researchers at Daiichi Sankyo (Germany)?

Ranked on the composite score, TATSUO HANEISHI, Hiroshi Sakurai and Kazunori Fujimoto lead among researchers whose main affiliation is Daiichi Sankyo (Germany).

  1. 1 TATSUO HANEISHI Germany · #554,414 worldwide 89 citations · 17 works
  2. 2 Hiroshi Sakurai Germany · #751,268 worldwide 8 citations · 17 works
  3. 3 Kazunori Fujimoto Germany · #1,329,422 worldwide 25 citations · 15 works
  4. 4 Tetsufumi Koga Germany · #1,540,283 worldwide 10 citations · 15 works
  5. 5 Sunao Manabe Germany · #1,550,732 worldwide 19 citations · 21 works
  6. 6 Takashi Yamoto Germany · #1,556,938 worldwide 14 citations · 19 works
All ranked researchers at Daiichi Sankyo (Germany)

Which keywords describe research at Daiichi Sankyo (Germany)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Clinical Trials, Breast Cancer, Genetic Variants, Monoclonal Antibody, Targeted Therapy, Cardiovascular Disease Prevention and Statins.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy11▲ 14×15 topics
  2. Clinical Trials11▲ 14×8 topics
  3. Breast Cancer8▲ 29×7 topics
  4. Quality of Life7▲ 4.2×14 topics
  5. Genetic Variants6▲ 32×3 topics
  6. Monoclonal Antibody6▲ 99×2 topics
  7. Cardiovascular Disease Prevention6▲ 58×2 topics
  8. Targeted Therapy6▲ 23×4 topics
  9. Statins5▲ 65×2 topics
  10. Cholesterol-lowering5▲ 101×1 topic
  11. HER25▲ 159×1 topic
  12. LDL Cholesterol5▲ 132×1 topic
  13. Trastuzumab5▲ 100×1 topic
  14. Inflammation5▲ 2.1×34 topics
  15. Cost-effectiveness Analysis4▲ 42×1 topic
  16. Health Utility Measures4▲ 42×1 topic
  17. Prognostic Factors4▲ 8.2×6 topics
  18. Biomarkers4▲ 5.0×10 topics
  19. Metastatic Breast Cancer4▲ 60×2 topics
  20. Anticoagulant Therapy4▲ 26×4 topics
  21. Catheter Ablation4▲ 27×2 topics
  22. Clinical Practice Guidelines4▲ 6.0×9 topics
  23. Guidelines4▲ 6.9×6 topics
  24. Immunotherapy3▲ 4.3×10 topics
  25. Atrial Fibrillation3▲ 29×1 topic
  26. Stroke Prevention3▲ 23×1 topic
  27. ALK Inhibitors3▲ 41×1 topic
  28. EGFR Mutations3▲ 41×1 topic
  29. Treatment Guidelines3▲ 12×3 topics
  30. Metastasis3▲ 7.3×6 topics
  31. Radiotherapy3▲ 6.0×8 topics
  32. Glycosylation2▲ 19×2 topics
  33. Monoclonal Antibodies2▲ 23×3 topics
  34. Cell Cycle Control2▲ 66×2 topics
  35. Genomic Profiles2▲ 45×1 topic
  36. Hypertension2▲ 6.8×6 topics
  37. Small-Cell Lung Cancer2▲ 45×1 topic
  38. CDK4/6 Inhibitors2▲ 75×1 topic
  39. Molecular Subtypes2▲ 22×2 topics
  40. Palbociclib2▲ 75×1 topic

Which research topics does Daiichi Sankyo (Germany) publish most on?

By volume in 2022–2025: Lipoproteins and Cardiovascular Health, HER2/EGFR in Cancer Research, Health Systems, Economic Evaluations, Quality of Life and Atrial Fibrillation Management and Outcomes.

  1. 1 Lipoproteins and Cardiovascular Health Surgery 5 works
  2. 2 HER2/EGFR in Cancer Research Oncology 5 works
  3. 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 4 works
  4. 4 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 3 works
  5. 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
  6. 6 Lung Cancer Research Studies Oncology 2 works
  7. 7 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
  8. 8 Pharmaceutical Economics and Policy Economics and Econometrics 2 works
  9. 9 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  10. 10 Cancer Treatment and Pharmacology Oncology 2 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available63.0%not open37.0%

World: 28% of research is openly available.

with international co-authors65.0%domestic only35.0%

World: 19% is written across borders.

How has Daiichi Sankyo (Germany)'s research output changed?

Output in 2018–2022 was 9% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Munich

All research institutions in Munich

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.